ABT241018P117000
- 0.48
- -0.18-27.27%
Abbott Laboratories Newsroom
Mizuho Securities Maintains Abbott Laboratories(ABT.US) With Hold Rating, Raises Target Price to $130
Abbott Labs Is Maintained at Neutral by Mizuho
Abbott Labs Price Target Raised to $130.00/Share From $115.00 by Mizuho
These Analysts Increase Their Forecasts On Abbott Laboratories After Better-Than-Expected Q3 Earnings
A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $125 to $146
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
Meta To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Thursday
Abbott Laboratories Analyst Ratings
Goldman Sachs Remains a Buy on Abbott Laboratories (ABT)
Abbott Laboratories (ABT) Gets a Buy From Piper Sandler
Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Abbott Laboratories (ABT)
Travis Steed Reiterates Buy Rating on Abbott Laboratories Amid Promising Growth and Under-Ownership Potential
Morgan Stanley Adjusts Price Target on Abbott Laboratories to $117 From $107, Maintains Equalweight Rating
Abbott Laboratories: Buy Rating Reaffirmed Amid Strong Medical Device Performance and Positive Long-Term Growth Outlook
Express News | Abbott : Piper Sandler Raises Target Price to $133 From $131
Abbott Laboratories (ABT) Q3 2024 Earnings Call Highlights: Strong Growth in Diabetes Care and ...
Why Abbott Laboratories Stock Was a Winner on Wednesday
Cautious Outlook on Abbott Laboratories Amid Mixed Financials and Legal Challenges
Abbott Laboratories: Strong Growth Prospects and Strategic Positioning Drive Buy Rating
Earnings Call: Abbott Reports 8% Organic Sales Growth, Raises Guidance